BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu YP, Guo T, Wang BJ, Dong JH, Zhu JF, Liu Z, Lu MJ, Yang DL. Replication of clinical hepatitis B virus isolate and its application for selecting antiviral agents for chronic hepatitis B patients. World J Gastroenterol 2008; 14(22): 3490-3496 [PMID: 18567076 DOI: 10.3748/wjg.14.3490] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Zhou Y, Li X, Niu M, Chen R, Shao J, Si L, Luo D, Lin Y, Li L, Zhang K, Xiao X, Xu Z, Liu M, Lu M, Zoulim F, Xu D. Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice. Emerg Microbes Infect. 2019;8:354-365. [PMID: 30866789 DOI: 10.1080/22221751.2019.1584018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
2 Huang W, Li X, Yi M, Zhu S, Chen W. Targeted delivery of siRNA against hepatitis B virus by preS1 peptide molecular ligand. Hepatol Res. 2014;44:897-906. [PMID: 23799901 DOI: 10.1111/hepr.12189] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]